Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 21.47 as of Saturday, August 1, 2026.
Forward PE Ratio (21.47) = Close Price ($112.52) / Consensus Forward EPS ($5.24)
FORWARD PE RATIO
21.47
SECTOR MEDIAN · HEALTHCARE
19.07
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+12.61%
vs the sector median at left
Revvity, Inc.
Market Cap
$12.55B
Forward PE Ratio
21.47
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Revvity, Inc. (RVTY) | $12.55B | 21.47 |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 14.99 |
| Baxter International Inc. (BAX)vs › | $13.51B | 13.22 |
| Insulet Corp. (PODD)vs › | $11.45B | 25.51 |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 37.48 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | 20.94 |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 15.62 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Solventum Corporation (SOLV)vs › | $14.80B | 13.04 |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | N/A |
Trailing P/E
53.6
reported TTM EPS
Forward P/E
21.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $5.24 implies +149.5% EPS growth vs the reported trailing $2.10.
At today's $112.52 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-28 | $5.24 | $5.23 – $5.25 | 6 | 21.5x |
| 2027-12-28 | $5.81 | $5.80 – $5.83 | 6 | 19.4x |
| 2028-12-28 | $6.44 | $6.33 – $6.55 | 2 | 17.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
